Using Fusion Enzyme Technology to Design Better Catalysis for Renewable Energy, Waste to Energy and Fermentation Markets
Our patent pending technology platform is based on the idea that we can develop better catalysis by combining biological molecules with desired properties into one product called fusion enzymes. We design and construct fusion enzymes based on industrial process parameters. That means our enzymes are designed to work in a commercial process and by combining desired activities into one molecule reduces manufacturing and operating costs.
Our philosophy is to convert waste streams into energy at the source of production. We do this by offering our clients an integrated process that combines three operations: 1) Bio-fuel production, 2) composting and 3) green house integration (BCG Concept). The BCG Concept works because the waste produced by one operation becomes the input for the next. The BCG Concept is sustainable because multiple revenue streams are generated from the combined operations. The BCG Concept is profitable because it converts waste into revenue while reducing or eliminating costs for transporting waste.
The BCG Concept is offered as a membership to C2B. The cost of the membership is based on the profit a client generates from implementing the BCG Concept. The client is responsible for all start up costs and owns all of the equipment and technology to operate. The membership fee covers C2B consulting and fusion enzyme technology transfer. The enzyme technology is used to produce bio-fuel and C2B will provide all of the intructions and expression systems to produce required catalysis on-site. We believe that offering customers on-site enzyme manufacturing services can reduce the cost of consumables by 60% - 90% because downstream processing efforts are not required. Combining the on-site service with fusion enzyme use may provide another 30% - 50% reduction in enzyme costs. Membership also provides access to future technology upgrades and continued support and consultation services.
The fusion enzyme technology was partially funded by the Department of Energy (DoE). C2 Biotechnologies, LLC was awarded a Phase I Small Business Innovative Research (SBIR) grant for $100,000. Over the course of 9 months we will use our technology platform to construct a cellulosic fusion enzyme. Enzymatic hydroylosis of cellulose requires at least three activities. By combining two or more activities into one molecule may reduce enzyme costs by 30%.